Head to Head Analysis: Global Cord Blood (NYSE:CORBF) vs. agilon health (NYSE:AGL)

Global Cord Blood (NYSE:CORBFGet Free Report) and agilon health (NYSE:AGLGet Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation and analyst recommendations.

Valuation & Earnings

This table compares Global Cord Blood and agilon health’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Global Cord Blood $196.12 million N/A $79.04 million N/A N/A
agilon health $4.32 billion 0.48 -$262.60 million ($0.65) -7.69

Global Cord Blood has higher earnings, but lower revenue than agilon health.

Profitability

This table compares Global Cord Blood and agilon health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Global Cord Blood N/A N/A N/A
agilon health -5.76% -21.74% -8.89%

Analyst Recommendations

This is a summary of recent recommendations for Global Cord Blood and agilon health, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Cord Blood 0 0 0 0 N/A
agilon health 1 12 4 0 2.18

agilon health has a consensus price target of $9.46, indicating a potential upside of 89.29%. Given agilon health’s higher probable upside, analysts plainly believe agilon health is more favorable than Global Cord Blood.

Volatility & Risk

Global Cord Blood has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500. Comparatively, agilon health has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500.

About Global Cord Blood

(Get Free Report)

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.